[EN] NOVEL OLIGOSACCHARIDE GLYCOSIDES HAVING MAMMALIAN IMMUNOSUPPRESSIVE AND TOLEROGENIC PROPERTIES<br/>[FR] NOUVEAUX GLYCOSIDES OLIGOSACCHARIDIQUES AYANT DES PROPRIETES IMMUNOSUPPRESSIVES ET TOLEROGENES CHEZ LES MAMMIFERES
申请人:GLYCOMED, INC.
公开号:WO1997018222A2
公开(公告)日:1997-05-22
(EN) Disclosed are novel oligosaccharide glycosides having mammalian immunosuppressive and tolerogenic properties, pharmaceutical compositions containing such oligosaccharide glycosides and methods of using such oligosaccharide glycosides to modulate cell-mediated immune responses in a mammal.(FR) L'invention concerne de nouveaux glycosides oligosaccharidiques possédant des propriétés immunosuppressives et tolérogènes chez les mammifères, des compositions pharmaceutiques les contenant et des procédés d'utilisation de ces glycosides pour moduler les réponses immunes induites par les cellules chez un mammifère.
[EN] MONOSACCHARIDE DERIVATIVES<br/>[FR] DERIVES DE MONOSACCHARIDES
申请人:UNIV DUBLIN
公开号:WO2003018598A2
公开(公告)日:2003-03-06
Monosaccharide (pyranoside) conjugates of the formula have been found to be useful as enhancers and/or inhibitors of heparin binding to FGF. The compounds have the potential to be useful in regenerative medicine or for treatment of pathological disease associated with FGF activity or as glycoprocessing inhibitors. In particular the compounds are potential modulators of fibroblast growth factors (FGFs) and fibronectin, as mitogenic agents and as inhibitors of endothelial cell survival.